Skip to main content

Game-changing uPAR-targeting dye for guiding surgical treatment of cancer

Searching for OpenAIRE data...


IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts

Author(s): Sorel Kurbegovic, Karina Juhl, Kasper Kildegaard Sørensen, Julie Leth, Gro Linno Willemoe, Anders Christensen, Yvonne Adams, Anja Ramstedt Jensen, Christian von Buchwald, Jane Skjøth-Rasmussen, Michael Ploug, Knud J. Jensen, Andreas Kjaer
Published in: Theranostics, Issue 11/15, 2021, Page(s) 7159-7174, ISSN 1838-7640
DOI: 10.7150/thno.49787

Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial

Author(s): Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso, Andreas Kjaer
Published in: Journal of Nuclear Medicine, Issue 62/3, 2021, Page(s) 354-359, ISSN 0161-5505
DOI: 10.2967/jnumed.120.248120